FELIPE ARIAS: Open Payments
NPI 1124055371 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 14 payments from 7 companies in 2025. Trend: 2023 $370 · 2024 $49 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 5 | $108 |
| Gilead Sciences, Inc. | 3 | $75 |
| Theratechnologies Inc. | 2 | $38 |
| ABBVIE INC. | 1 | $26 |
| Exact Sciences Corporation | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: DOVATO, EGRIFTA, Yeztugo, VRAYLAR, Cologuard Collection Kit, REXULTI, FARXIGA.
Industry payments across PA — which companies pay providers there.
